Pages that link to "Q36836016"
Jump to navigation
Jump to search
The following pages link to Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis. (Q36836016):
Displaying 6 items.
- Metformin attenuates myocardial ischemia-reperfusion injury via up-regulation of antioxidant enzymes. (Q41444311) (← links)
- Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects (Q47739163) (← links)
- Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology (Q57180762) (← links)
- Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study (Q91797819) (← links)
- Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis (Q92293031) (← links)
- Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages (Q96017824) (← links)